This COVID-19 roundup includes coverage on the FDA-approved oral antiviral treatment for adults with mild-to-moderate COVID-19, how antidepressant medication may lower the incidence of COVID-19, a study...
Following a multicenter clinical trial, a new treatment for pneumonia caused by Acinetobacter baumannii-calcoaceticus has been approved for use in adults.
The American Thoracic Society released a set of guidelines addressing the use of pulmonary rehabilitation in patients with chronic obstructive pulmonary disorder and other respiratory diseases.
Following three clinical trials, the FDA has approved a new preventive treatment for neonates, infants, and toddlers that prevents respiratory syncytial virus (RSV) in those age populations.
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
Researchers determined the risk of death and health care costs in patients with COPD who undergo surgery compared with patients without COPD who undergo surgery.
Following a multicenter study, the FDA approved the combination of albuterol and budesonide—an inhaled corticosteroid—for the treatment of asthma in adults.
Researchers aimed to investigate the possibility of differentiating between eosinophil subsets in the induced sputum of patients with allergic asthma and to ascertain the distribution of these subsets in...
